Search research articles
Contact Us
Filters
Showing results (611-620 of 671) with videos related to
Page
of 68
Sort By:
Bone Marrow Transplantation
|
December 5, 2025
Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myeloma
Oren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Frontiers in Immunology
|
March 15, 2021
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells
Enli Liu, Sonny O T Ang, Lucila Kerbauy, et al.
Bone Marrow Transplantation
|
December 20, 2016
Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients
B S Andersson, P F Thall, B C Valdez, et al.
Transplantation and Cellular Therapy
|
January 2, 2025
Outcomes of Standard-Risk Multiple Myeloma Patients Who Undergo Upfront Autologous Hematopoietic Stem Cell Transplantation
Oren Pasvolsky, Curtis Marcoux, Zhongya Wang, et al.
Blood
|
February 2, 2018
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion
Betül Oran, Rima M Saliba, Yudith Carmazzi, et al.
Leukemia & Lymphoma
|
January 29, 2026
Lenalidomide maintenance after delayed or salvage autologous stem cell transplantation
Asad A Haider, Curtis Marcoux, Denái R Milton, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 27, 2026
Daratumumab-Based Second Line Therapy Improves Outcomes After VRD Induction, Upfront Autologous Transplant, and Lenalidomide Maintenance
Oren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Cancer
|
April 1, 2021
Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors
Koji Sasaki, Hagop M Kantarjian, Nicholas J Short, et al.
British Journal of Haematology
|
March 30, 2025
Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response
Oren Pasvolsky, Muhammad Bilal Abid, Denái R Milton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease
J L Gajewski, G L Phillips, K A Sobocinski, et al.
Page
of 68
Search research articles
Search
Showing results (611-620 of 671) with videos related to
Sort By:
Page
of 68
Bone Marrow Transplantation
|
December 5, 2025
Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myeloma
Oren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Frontiers in Immunology
|
March 15, 2021
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells
Enli Liu, Sonny O T Ang, Lucila Kerbauy, et al.
Bone Marrow Transplantation
|
December 20, 2016
Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients
B S Andersson, P F Thall, B C Valdez, et al.
Transplantation and Cellular Therapy
|
January 2, 2025
Outcomes of Standard-Risk Multiple Myeloma Patients Who Undergo Upfront Autologous Hematopoietic Stem Cell Transplantation
Oren Pasvolsky, Curtis Marcoux, Zhongya Wang, et al.
Blood
|
February 2, 2018
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion
Betül Oran, Rima M Saliba, Yudith Carmazzi, et al.
Leukemia & Lymphoma
|
January 29, 2026
Lenalidomide maintenance after delayed or salvage autologous stem cell transplantation
Asad A Haider, Curtis Marcoux, Denái R Milton, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 27, 2026
Daratumumab-Based Second Line Therapy Improves Outcomes After VRD Induction, Upfront Autologous Transplant, and Lenalidomide Maintenance
Oren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Cancer
|
April 1, 2021
Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors
Koji Sasaki, Hagop M Kantarjian, Nicholas J Short, et al.
British Journal of Haematology
|
March 30, 2025
Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response
Oren Pasvolsky, Muhammad Bilal Abid, Denái R Milton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease
J L Gajewski, G L Phillips, K A Sobocinski, et al.
Page
of 68